CA Patent

CA2886402A1 — Tazobactam arginine antibiotic compositions

Assigned to Merck Sharp and Dohme LLC · Expires 2014-04-03 · 12y expired

What this patent protects

This disclosure provides compositions comprising a beta- lactam compound and crystalline tazobactam arginine, and related methods and uses of these compositions.

USPTO Abstract

This disclosure provides compositions comprising a beta- lactam compound and crystalline tazobactam arginine, and related methods and uses of these compositions.

Drugs covered by this patent

delafloxacin-meglumine (DELAFLOXACIN MEGLUMINE)

Patent Metadata

Patent number: CA2886402A1
Jurisdiction: CA
Classification: —
Expires: 2014-04-03
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.